Abstract
The best initial treatment of human immunodeficiency virus (HIV)-infected patients with esophageal symptoms is unknown. The outcome, including safety and cost-effectiveness, of fluconazole compared with endoscopy as a treatment strategy for HIV-infected patients with new-onset esophageal symptoms was evaluated. During a 53-month period, 134 HIV-infected patients with esophageal symptoms were randomized prospectively to groups receiving either standard doses of fluconazole or endoscopy. Among the 68 patients in the fluconazole group, a complete symptomatic response was observed in 56 patients (82%), usually within 1 week. The most common endoscopic findings in the 66 patients in the endoscopy group included Candida esophagitis alone in 42 patients (64%) and ulcerative esophagitis in 10 patients (15%). Patients responding to empirical antifungal therapy or who had Candida esophagitis alone at endoscopy were less like to have severe symptoms (P = 0.027) or odynophagia as the only symptom (P < 0.001) but more frequently had odynophagia and dysphagia (P = 0.007) and thrush (P = 0.002). Empirical fluconazole was cost-effective, saving $738.16 per patient. Empirical oral antifungal therapy with fluconazole is highly efficacious, safe,...Continue Reading
Citations
Jun 1, 1997·Alimentary Pharmacology & Therapeutics·C M Wilcox, K E Mönkemüller
Aug 26, 2000·The Pediatric Infectious Disease Journal·C C ChiouT J Walsh
Aug 29, 2003·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Syed Ali Zaidi, Joseph S Cervia
Sep 23, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michele I Morris, Mark Villmann
Dec 17, 2008·Digestive Diseases and Sciences·Sharad SharmaNicolas Jabbour
Jul 6, 2013·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N AsayamaN Uemura
Mar 7, 2009·World Journal of Gastroenterology : WJG·Ana Luiza Werneck-Silva, Ivete Bedin Prado
Apr 5, 2013·PloS One·So NishimuraNaomi Uemura
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Mar 11, 2005·Expert Opinion on Emerging Drugs·Anne Chen, Jack D Sobel
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Neelima Reddy, C Mel Wilcox
Jun 6, 2009·Tropical Medicine & International Health : TM & IH·Rony ZachariahAnthony D Harries
Jun 16, 2011·Mycoses·Markus RuhnkeUNKNOWN Paul-Ehrlich-Society for Chemotherapy
Sep 14, 2000·Comprehensive Therapy·K E Mönkemüller, C M Wilcox
Dec 4, 2020·HIV Medicine·D R ChadwickMbj Beadsworth
Sep 22, 1998·The Journal of the Association of Nurses in AIDS Care : JANAC·C J Thomas
Jun 1, 1997·Gastroenterology Clinics of North America·F Clayton, C H Clayton
Jun 1, 1997·Gastroenterology Clinics of North America·C M Noyer, D Simon
Jun 27, 2000·Gastroenterology·S Banerjee, J T LaMont
Sep 18, 2021·Endoscopy·Roos E PouwJeanin E van Hooft
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America